Status:
UNKNOWN
Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer
Lead Sponsor:
Samsung Medical Center
Conditions:
Metastatic Lung Non-Small Cell Carcinoma
EGFR T790M
Eligibility:
All Genders
19+ years
Brief Summary
* It is to evaluate the safety and effectiveness of a lasertinib(LECLAZA) single drug in a actual medical environment for patients 1. Primary Purpose: Progression-free survival (PFS) 2. Secondary...
Detailed Description
□ the purpose of the study The study aims to explore the safety, efficacy and resistance of test drugs in patients with local progressive or metastatic epithelial growth factor T790M mutant non-small ...
Eligibility Criteria
Inclusion
- Prospective cohort
- adults over the age of 19
- Easter Cooperative Oncology Group performance 0-4
- Patients who are eligible for or are being treated for test medication as per permit: patients with NSCLC with local progressive or metastatic EGFR T790M mutation who have previously been treated with Generation 1 or Generation 2 EGFR TKI
- EGFR T790M mutation allows for all results identified in tumor tissue or plasma
- Patients with brain MR within 3 months of study participation
- Rectrospective cohort
- adults over the age of 19
- Patients who are already using the test drug according to the domestic authorization of the test drug
Exclusion
- Patients who have a history of hypersensitivity to test drugs or drugs of similar chemical structure or similar family to those of test drugs
- Pregnant women or lactating women
- Patients participating in other interventional clinical studies
Key Trial Info
Start Date :
July 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
900 Patients enrolled
Trial Details
Trial ID
NCT05377788
Start Date
July 31 2022
End Date
June 30 2024
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351